Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Salah‐Eddin Al‐Batran
,
Nils Homann
,
Claudia Pauligk
,
Salah‐Eddin Al‐Batran
,
Nils Homann
,
Claudia Pauligk
,
Thorsten Oliver Goetze
,
Jens Meiler
,
Stefan Kasper
,
Hans‐Georg Kopp
,
Frank Mayer
,
Georg Martin Haag
,
Kim Barbara Luley
,
Udo Lindig
,
Wolff Schmiegel
,
Michael Pohl
,
Jan Stoehlmacher
,
Gunnar Folprecht
,
Stephan Probst
,
Nicole Prasnikar
,
Wolfgang Fischbach
,
Rolf Mahlberg
,
Jörg Trojan
,
Michael Koenigsmann
,
Uwe M. Martens
,
Peter Thuss‐Patience
,
Matthias Egger
,
Andreas Block
,
Volker Heinemann
,
Gerald Illerhaus
,
Markus Moehler
,
Michael Schenk
,
Frank Kullmann
,
Dirk Behringer
,
Michael Heike
,
Daniel Pink
,
Christian Teschendorf
,
Carmen Löhr
,
Helga Bernhard
,
Gunter Schuch
,
Volker Rethwisch
,
Ludwig Fischer von Weikersthal
,
Jörg T. Hartmann
,
Michael Kneba
,
S Daum
,
Karsten Schulmann
,
J. Weniger
,
Sebastian Belle
,
Timo Gaiser
,
Fuat Oduncu
,
Martina Güntner
,
Wael Hozaeel
,
Alexander Reichart
,
Elke Jäger
,
Thomas Kraus
,
Stefan Mönig
,
Wolf O. Bechstein
,
Martin Schüler
,
Harald Schmalenberg
,
Ralf–Dieter Hofheinz
2019
The Lancet
2,355 citations